What NVS paid for a Phase 2 MS drug is 5 times our
Post# of 72440
Posted On: 08/21/2015 12:55:27 PM
What NVS paid for a Phase 2 MS drug is 5 times our market cap.
FIVE times. And with royalties and another 200 million of progress payments.
We're about to enter Phase 3 with Brilacidin.
Shorts should be very scared. I hope they are all massively short when a deal is announced.
Remember, one day DNDN closed at 7. The next day it opened at 21.
It could happen for us.
FIVE times. And with royalties and another 200 million of progress payments.
We're about to enter Phase 3 with Brilacidin.
Shorts should be very scared. I hope they are all massively short when a deal is announced.
Remember, one day DNDN closed at 7. The next day it opened at 21.
It could happen for us.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼